USA - NASDAQ:OKUR - US68277Q1058 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to OKUR. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-01-28 | Jones Trading | Initiate | Buy |
| 2024-12-05 | Leerink Partners | Initiate | Outperform |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-10 | Oppenheimer | Initiate | Outperform |
12 analysts have analysed OKUR and the average price target is 30.6 USD. This implies a price increase of 774.04% is expected in the next year compared to the current price of 3.501.
The consensus rating for ONKURE THERAPEUTICS INC-A (OKUR) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ONKURE THERAPEUTICS INC-A (OKUR) is 12.